The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy.
AffiliationDepartment of Radiotherapy, Christie Hospital Cancer Research Campaign, Manchester, UK.
MetadataShow full item record
AbstractLocal control of cancer by radiotherapy may be prejudiced by accelerated tumour clonogen repopulation particularly during protracted treatment schedules. A series of 496 cases of T2 and T3 larynx cancer treated here by radiotherapy has been studied to examine the impact on local control of treatment durations ranging from 9 to 41 days. Data were analysed using a linear-quadratic formulation describing the fractionation sensitivity, with the incorporation of a parameter relating to treatment time. Using combined T2 and T3 data, the increase in dose required to maintain a constant local control (the time factor) was between 0.5 and 0.6 Gy per day. These values are similar to those reported for 4 weeks or more in the literature. Also, the calculated dose to control 50% of tumours, given over the standard Christie duration of 21 days, was on the line projected back from literature data over 28-66 days. The present data are consistent with the presence of such a time factor following a lag phase of not more than 3 weeks after starting radiotherapy. Hence, further consideration should be given to using shorter overall treatment times in radiotherapy for head and neck cancer.
CitationThe effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy. 1992, 24 (4):215-20 Radiother Oncol
JournalRadiotherapy and Oncology
- Modelling the optimal radiotherapy regime for the control of T2 laryngeal carcinoma using parameters derived from several datasets.
- Authors: Roberts SA, Hendry JH, Slevin NJ
- Issue date: 1997 Dec 1
- Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3.
- Authors: Terhaard CH, Kal HB, Hordijk GJ
- Issue date: 2005 May 1
- Time factors in larynx tumor radiotherapy: lag times and intertumor heterogeneity in clinical datasets from four centers.
- Authors: Roberts SA, Hendry JH
- Issue date: 1999 Dec 1
- Influence of radiotherapy treatment time on control of laryngeal cancer: comparisons between centres in Manchester, UK and Toronto, Canada.
- Authors: Hendry JH, Roberts SA, Slevin NJ, Keane TJ, Barton MB, Agren-Cronqvist A
- Issue date: 1994 Apr
- Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
- Authors: Ricciardelli EJ, Weymuller EA Jr, Koh WJ, Austin-Seymour M, DeSautel MG, Laramore GE
- Issue date: 1994 Jul